Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Употребление табака и отказ от курения при психических расстройствах: доклад Национального института психического здоровья
2008-11-21
SCID: 54.1/yhm5kgfs
Discuss with AI
mental health settingsnicotine dependencepsychiatric disorderssmoking cessationtobacco use
Figures from the paper
Abstract (AI)
The National Institute of Mental Health (NIMH) convened a meeting in September 2005 to review tobacco use and dependence and smoking cessation among those with mental disorders, especially individuals with anxiety disorders, depression, or schizophrenia. Smoking rates are exceptionally high among these individuals and contribute to the high rates of medical morbidity and mortality in these individuals. Numerous biological, psychological, and social factors may explain these high smoking rates, including the lack of smoking cessation treatment in mental health settings. Historically, "self-medication" and "individual rights" have been concerns used to rationalize allowing ongoing tobacco use and limited smoking cessation efforts in many mental health treatment settings. Although research has shown that tobacco use can reduce or ameliorate certain psychiatric symptoms, overreliance on the self-medication hypothesis to explain the high rates of tobacco use in psychiatric populations may result in inadequate attention to other potential explanations for this addictive behavior among those with mental disorders. A more complete understanding of nicotine and tobacco use in psychiatric patients also can lead to new psychiatric treatments and a better understanding of mental illness. Greater collaboration between mental health researchers and nicotine and tobacco researchers is needed to better understand and develop new treatments for cooccurring nicotine dependence and mental illness. Despite an accumulating literature for some specific psychiatric disorders and tobacco use and cessation, many unstudied research questions remain and are a focus and an emphasis of this review.
Key Findings
1
Although nicotine may alleviate some psychiatric symptoms, overreliance on the self-medication hypothesis can obscure other explanations for tobacco dependence.
2
Closer collaboration between mental-health and tobacco researchers is needed to develop treatments for co-occurring nicotine dependence and mental illness, while many research questions remain unanswered.
3
High tobacco-use rates likely reflect interacting biological, psychological, and social factors, including inadequate access to cessation treatment in mental-health settings.
4
Historical appeals to self-medication and individual rights have contributed to limited smoking-cessation efforts in psychiatric treatment settings.
5
Smoking prevalence is exceptionally high among people with anxiety disorders, depression, or schizophrenia, contributing substantially to their medical morbidity and mortality.
Research Object
Tobacco use, nicotine dependence, and smoking cessation among individuals with psychiatric disorders, especially anxiety disorders, depression, or schizophrenia
Research Subject
Smoking prevalence, contributing biological, psychological, and social factors, psychiatric symptom effects, and cessation-treatment needs in people with mental disorders
Publication Details
Publication Date
2008-11-21
Journal
Publisher
ISSN
Cited by
732
Access Type
Author Information
Download PDF
Subscribe to digest